# Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)

> **NCT01254344** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 599 (actual)

## Conditions studied

- Infection
- Surgical Site Infection

## Interventions

- **DRUG:** ertapenem sodium
- **DRUG:** ceftriaxone sodium
- **DRUG:** placebo to metronidazole
- **DRUG:** metronidazole

## Key facts

- **NCT ID:** NCT01254344
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 599 (ACTUAL)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01254344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01254344, "Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01254344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*